Get advice for managing Multiple Sclerosis: Watch the video.

Teriflunomide Pregnancy and Breastfeeding Warnings

Teriflunomide is also known as: Aubagio

Teriflunomide Pregnancy Warnings

FDA pregnancy category: X Use of teriflunomide is contraindicated. Comments: Use of adequate methods of contraception by both females and males in encouraged during and for 2 years after stopping treatment.

Animal studies resulted in decreased growth, eye and skin abnormalities, high incidences of fetal malformation, postnatal death, and embryofetal death at doses not associated with maternal toxicity. There are no controlled data in human pregnancy. Teriflunomide has been detected in human semen. A teriflunomide pregnancy registry has been established to monitor fetal outcomes of exposed pregnant women. Healthcare providers are encouraged to enroll pregnant women (pregnant women can enroll themselves) by calling 1-800-745-4447, option 2 (USA). FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

Teriflunomide Breastfeeding Warnings

A decision should be made to discontinue breast-feeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here